Abstract:Abstract: Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belonging to the nuclear receptor family. PPARs function as regulators of lipid and lipoprotein metabolism and glucose homeostasis and influence cellular proliferation, differentiation and apoptosis. PPARα is highly expressed in tissues such as liver, muscle, kidney and heart, where it stimulates the β-oxidative degradation of fatty acids. PPARγ is predominantly expressed in intestine and adipose tissue. PPARγ triggers adipocyte differentiation and promotes lipid storage. The hypolipidemic fibrates and the antidiabetic glitazones are synthetic ligands for PPARα and PPARγ, respectively. Furthermore, fatty acids and eicosanoids are natural PPAR ligands: PPARα is activated by leukotriene B4, whereas prostaglandin J2 is a PPARγ ligand. These observations suggested a potential role for PPARs not only in metabolic but also in inflammation control. The first evidence for a role of PPARα in inflammation control came from the demonstration that PPARα deficient mice display a prolonged response to inflammatory stimuli. It was suggested that PPARα deficiency results in a reduced β-oxidative degradation of these inflammatory fatty acid derivatives. More recently, PPAR activators were shown to inhibit the activation of inflammatory response genes (such as IL-2, IL-6, IL-8, TNFα and metalloproteases) by negatively interfering with the NF-κB, STAT and AP-1 signalling pathways. PPAR activators exert these anti-inflammatory activities in different immunological and vascular wall cell types such as monocyte/macrophages, endothelial, epithelial and smooth muscle cells in which PPARs are expressed. These recent findings indicate a modulatory role for PPARs in the control of the inflammatory response with potential therapeutic applications in inflammation-related diseases, such as atherosclerosis and inflammatory bowel disease.

Peroxisome Proliferator–Activated Receptor-α: A Pivotal Regulator of the Gastrointestinal Tract

The PPARα Regulation of the Gut Physiology in Regard to Interaction with Microbiota, Intestinal Immunity, Metabolism, and Permeability

Hepatic PPARα Function is Controlled by Polyubiquitination and Proteasome‐mediated Degradation Through the Coordinated Actions of PAQR3 and HUWE1

Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation

The global perspective on peroxisome proliferator-activated receptor (PPAR) in ectopic fat deposition: A review

The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases

Peroxisome Proliferator-Activated Receptor Γ and Colorectal Cancer.

Modulation Of Peroxisome Proliferator-Activated Receptor Gamma (Ppar Gamma) By Conjugated Fatty Acid In Obesity And Inflammatory Bowel Disease

Peroxisome Proliferator-Activated Receptor-γ in Vascular Biology

1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons

[Peroxisome Proliferator-Activated Receptors and Atherosclerosis].

Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders

Interactions between Host PPARs and Gut Microbiota in Health and Disease

PPARs as Nuclear Receptors for Nutrient and Energy Metabolism

Posttranslational Modifications of Peroxisome Proliferator-activated Receptor γ

Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα

Homeostatic Ppar Alpha Signaling Limits Inflammatory Responses To Commensal Microbiota In The Intestine

PPAR-: A key nuclear receptor in vascular function and remodeling

Role of PPARβ/δ in Inflammation

Peroxisome Proliferator-Activated Receptor Alpha Ligands And Modulators From Dietary Compounds: Types, Screening Methods And Functions

Targeting PPARs for therapy of atherosclerosis: A review